8 Best Online Weight Loss Clinics of 2026 (Vetted & Ranked)

Anyone can sell you a GLP-1 online in 2026. The best online weight loss clinics do something harder: they screen you like a real doctor’s office, turn away the wrong candidates, and answer your messages after the box arrives. That is the bar for this list. We ranked 8 telehealth clinics on screening rigor, clinician access after prescribing, video versus async intake, and refund fine print — not just the sticker price.

The spread is wide. Prices run from $99/month for flat-dose compounded semaglutide to $449/month for brand-name Zepbound at the highest dose. One clinic on this list carries a 2025 FDA warning letter. Another holds an F from the BBB with 662 complaints. Scores run from 8.8 (Very Good) down to 6.9 (Fair). Here is exactly where each one earns — and loses — its points.

1. Ro — Best Overall: Real Screening, Brand-Name Meds Only

Score: 8.8/10 (Very Good). Ro tops this ranking because it behaves most like an actual clinic. It requires that you have seen a healthcare provider within the last 3 years before it will treat you — a guardrail almost nobody else enforces. Eligibility decisions come back in about 2 days, and its July 2026 menu lists only FDA-approved brand-name GLP-1s: Wegovy (pen and pill), Zepbound, Foundayo, and off-label Ozempic. Zero compounded drugs.

Aftercare is the other half of the score. Ro Body includes 24/7 care-team access, unlimited provider messaging, dose titration, and side-effect support. Its insurance concierge checks your coverage free and files prior-authorization paperwork — with coverage, the medication may cost only a copay. It serves all 50 states plus D.C.

Pricing Structure

The membership is $39 the first month, then $149/mo (as low as $74/mo prepaid annually). Medication bills separately, and you are only charged the membership if you are found eligible.

Medication (cash pay)	First month	Ongoing
Wegovy pill / Foundayo pill	$149	$199-$299/mo
Wegovy pen	$199	$199-$399/mo
Zepbound KwikPen	$299	$399-$449/mo

Prices rise with dose — Ro’s own FAQ confirms Wegovy costs more at higher doses. Cheapest realistic first month: about $188 (pill plus membership). Ongoing on the monthly plan: $348-$598/mo all-in.

Pros & Cons

Pros: FDA-approved meds only, sourced through NovoCare and LillyDirect; cash prices stated to match manufacturer-direct channels; insurance concierge handles prior auths; the 3-year provider-visit rule is real clinical screening.

Cons: The $149/mo membership stacks on top of every medication price. Trustpilot sits around 3.7/5 across 2,300+ reviews, and the BBB file shows 610 complaints — many about membership billing. No compounded budget option, so cash costs beat only retail, not discounters.

2. Noom Med — Clinical Screening Wrapped in a Behavior Program

Score: 8.7/10 (Very Good). Noom Med is what happens when a psychology-based coaching app hires prescribers. Every plan bundles the full Noom curriculum, food logging, and 1:1 coaching with clinician care — the strongest behavioral support in this ranking. Screening has teeth: eligibility depends on BMI, medical history, and state, and Noom simply does not sell compounded plans in Alabama, Louisiana, or Mississippi.

Be clear on the medication, though. Noom’s compounded semaglutide and tirzepatide are not FDA-approved — Noom’s own disclaimer says the FDA has not reviewed them for safety, efficacy, or quality. Noom says they come from an FDA-regulated 503B outsourcing facility, which speaks to manufacturing oversight, not drug approval.

Pricing Structure

First months are cheap; quarters are not. Compounded semaglutide runs $129 the first month, then $249-$279/mo billed quarterly — that is a lump of up to $837 per 12 weeks. The microdose tier starts at $79, then $179-$199/mo. Tirzepatide: $149, then $299/mo. The brand-name path costs $39 the first month, then $99/mo — plus the drug itself, billed through insurance or cash (brand GLP-1s can top $1,000/mo without coverage).

One honesty flag: in July 2026 Noom’s pricing hub and its own product pages showed different recurring prices for the same plans ($249 vs $279 for semaglutide). That is sloppy for a company this size.

Pros & Cons

Pros: Medication, clinician care, and coaching in one flat subscription; a genuine Taper-Off Guarantee (free Noom or medication discounts if weight returns within 18 months after a 12-month course); BBB A+, accredited since 2021; FSA/HSA eligible.

Cons: Quarterly lump-sum billing after month one; compounded meds are not FDA-approved; not available in all 50 states; no published refund policy beyond cancel-anytime; the brand plan’s $99/mo does not include the drug.

3. Hers — Fast Async Prescribing With an FDA Asterisk

Score: 8.5/10 (Very Good). Hers is the speed play for women. Upload a government ID, complete the intake, and a licensed provider reviews it asynchronously — typically within 24 hours, no video visit in most states, no lab work. It operates in all 50 states, and provider messaging plus check-ins for dose titration are included in the membership.

Now the asterisk. On September 9, 2025, the FDA sent Hers a warning letter over false or misleading marketing of compounded semaglutide — which is not FDA-approved. Novo Nordisk sued the parent company in February 2026. To its credit, Hers has since pivoted: by March 2026 it centered on FDA-approved brand-name GLP-1s, limiting compounded product to medical necessity. The current menu is stronger because of it — but the letter stays on the record, and on this scorecard.

Pricing Structure

Two bills, always. The membership is $39 the first month, then $149/mo, and per Hers’ own site it does not include or guarantee a prescription. Medication is extra: Wegovy pill, Ozempic pill, and Foundayo pill from $149/mo; Wegovy pen and Ozempic from $199/mo; Zepbound vial or KwikPen from $299/mo. Retail Mounjaro/Zepbound pens sit at $1,899/mo for contrast. Cheapest first month lands near $193 with $5 shipping; about $303/mo ongoing, per third-party pricing reports. Those are “from” prices — higher doses cost more, and Hers does not publish the full dose ladder.

Pros & Cons

Pros: 24-hour async turnaround; oral and injectable brand options; BBB A+; backed by NYSE-listed Hims & Hers; brand prices of $149-$299/mo undercut $1,000+ retail.

Cons: Insurance not accepted, ever — you pay medication plus $149/mo membership out of pocket. Refunds only on unshipped orders canceled within 48 hours, and canceling medication does not cancel the membership. The 2025 FDA warning letter is a permanent scar.

4. bmiMD — Flat-Dose Pricing and a Same-Day Consult

Score: 8.2/10 (Very Good). bmiMD runs the smartest intake mechanic on this list: your card is authorized, not charged, until a board-certified provider actually approves you — usually via a same-day telehealth consultation. Found ineligible? The hold is released. That is a 100% no-charge outcome, and it means bmiMD’s screening has a financial spine.

The menu is compounded-only: semaglutide and tirzepatide injections, including microdose lines, plus cheap add-ons like metformin from $19/mo. These compounded GLP-1s are not FDA-approved — bmiMD discloses this plainly. It counters with published quality claims: third-party potency testing within ±10% every 3-6 months, USP 797 sterility, and endotoxin testing at FDA- and DEA-registered labs.

Pricing Structure

Compounded semaglutide: $99/mo on the 12-month plan (billed $1,188 upfront), $109/mo for 6 months, $119/mo for 3 months, $129/mo month-to-month. Tirzepatide: $139-$159/mo, with an $89.50 first-month promo for new members. The headline that matters: same price at every dose — your cost never climbs during titration. No membership fee, free shipping on subscriptions, HSA/FSA accepted.

Pros & Cons

Pros: Lowest flat pricing in this ranking; all-inclusive bundle (consult, meds, unlimited messaging, monthly check-ins); no charge if rejected; ships in 3-5 business days.

Cons: BBB C+, not accredited, 38 complaints. All sales are final once the pharmacy processes your order, and there is a $50 cancellation fee in the window between intake approval and pharmacy processing. Compounding pharmacy partners are not named. The cheapest rate demands $1,188 upfront.

5. TrimRx — The Strictest Intake Screen in the Bottom Half

Score: 7.8/10 (Good). TrimRx earns its spot on screening. Candidates generally need a BMI of 27+ plus at least one weight-related condition — closer to the FDA’s approved-label criteria than most telehealth rivals bother to get. Reviews are asynchronous over 24-48 hours, and per third-party reports, $0 is charged until a prescription is approved. Monthly check-ins, side-effect management, and dose adjustments are included.

The catch is age and polish. The operating company was founded in June 2024, its BBB profile is accredited but sits “under review” with no letter rating, and its own blog quotes tirzepatide at three different prices across posts. Compounded semaglutide and tirzepatide here are not FDA-approved finished products.

Pricing Structure

Compounded semaglutide starts at $199/mo — but only with an annual commitment. Month-to-month runs about $349/mo, per a March 2026 press release; third-party reviews report a 12-month prepaid rate near $174/mo. Tirzepatide: $349/mo promo, $449/mo standard, advertised as flat across the full 2.5-15 mg dose range. Brand-name options run $1,299-$1,399/mo. The price is all-in: consults, medication, syringes, sharps container, cold-chain shipping.

Pros & Cons

Pros: Real BMI-plus-comorbidity screening; no platform fee; $0 until approved; flat dose pricing on tirzepatide; HSA/FSA accepted; month-to-month escape hatch exists.

Cons: Trustpilot around 3.3/5 across roughly 727 reviews, polarized by billing surprises on multi-month plans; no refunds on unused prepaid months; pharmacies unnamed; pricing inconsistent across its own pages; barely two years of operating history.

6. MEDVi — Great Reviews, F-Grade Complaint Handling

Score: 7.6/10 (Good). MEDVi is the contradiction of 2026. Its Trustpilot profile shows roughly 4.4/5 across about 14,000 reviews — the biggest happy-customer base in this ranking. It names its compounding pharmacy partners (Triad Rx, RedRock, Beaker), a transparency step most rivals skip. And it sells rare daily dissolvable GLP-1 tablets alongside injections.

Then the other shoe: a BBB rating of F, 662 complaints, and 100 of them unanswered as of July 2026. Complaints cluster on unauthorized auto-renewals and cancellation friction. Clinically, prescribing runs through independent OpenLoop Health clinicians, usually within 24 hours — asynchronous in most states, with a required virtual face-to-face in some. Its compounded semaglutide and tirzepatide are not FDA-approved, which MEDVi’s own site states.

Pricing Structure

Compounded semaglutide injection: $179 the first month, then $299/mo refills — a 67% jump, though the refill rate stays flat regardless of dose. Tablets start at $249 first month with refills reported up to $369, and tirzepatide from $349 with refills of $399-$499, per third-party pricing reports. Brand-name plans add a $99 membership on top of medication; Ozempic is listed at $1,999/mo. One review site reports billing on a 28-day cycle — about 13 charges a year, not 12.

Pros & Cons

Pros: No membership fee on compounded plans; flat $299 refills that never rise with dose; named pharmacies; both injection and tablet forms; HSA/FSA accepted; free expedited shipping.

Cons: The BBB F with 100 unanswered complaints is the worst accountability record on this page. Refunds are generally unavailable once medication is dispensed. Tirzepatide and tablet refill prices are not published by MEDVi itself. Available in 49 states, not 50.

7. ReadyRx — Text-Only Care With a Money-Back Hook

Score: 7.2/10 (Good). ReadyRx stakes everything on one promise: lose at least 5% of your body weight in 28 weeks as prescribed, or get your money back. That is the boldest guarantee in this ranking, and it is backed by LegitScript certification and third-party lab testing with a certificate of analysis available on request.

The clinical model is thinner. Intake is a ~2-minute questionnaire reviewed by a board-certified provider, usually within 24 hours — but all care is text-message only. No video. No phone. Ever. At $299/mo, that is a hard ceiling on clinician access when nausea hits at 2 a.m. Its compounded semaglutide and tirzepatide are not FDA-approved, which the site discloses. And the site hides every price behind signup as $XXX placeholders — a transparency strike we penalize on every list.

Pricing Structure

Per third-party reviews: compounded semaglutide $299/mo month-to-month, or $249/mo with a $747 three-month prepay. Tirzepatide: $399/mo, no multi-month discount. Occasional first-month promos as low as $19 surface, per third-party reports. No membership fee — consults, unlimited messaging, and cold-chain shipping are bundled. Coverage gaps: semaglutide is unavailable in 7 states (AR, KS, KY, LA, MS, NM, SC); tirzepatide additionally excludes CA and NC.

Pros & Cons

Pros: 28-week/5% money-back guarantee; flat pricing across doses; approval and delivery in roughly 3-5 days; lab-tested product with COA; pause or cancel anytime.

Cons: Text-only communication; the guarantee requires 28 weeks of documented adherence before you see a dime; hidden pricing; tiny review base (~65 Trustpilot reviews) and no BBB accreditation; missing from up to 9 states.

8. OMZO — Cheap Promo, Thin Paper Trail

Score: 6.9/10 (Fair). OMZO sells the familiar bundle — compounded semaglutide, tirzepatide, oral GLP-1 tablets, and limited brand-name options — at competitive promo prices with no contract. Prescribing runs through unnamed third-party clinician networks; OMZO’s own terms state it is not a medical practice or a pharmacy. If a provider declines you, you get a full refund — a real guardrail, and the main reason this score is not lower.

The paper trail is the problem. OMZO’s terms list no legal entity name and no physical business address. Its funnel advertises a lose-weight-or-your-money-back guarantee, while the actual terms allow refunds only for medical ineligibility or billing errors. It has about 7 Trustpilot reviews and no BBB profile. Its compounded GLP-1s are not FDA-approved — OMZO’s footer says exactly that. For a medical relationship, this is the thinnest file on the page.

Pricing Structure

Per OMZO’s own terms: compounded semaglutide $199 the first month, then $299/mo — though funnel pages still advertise $179, a $20 discrepancy on its own storefront. Tirzepatide: $349 first month, then $399/mo. Oral GLP-1 tablets start at $249. Brand-name Ozempic appears at $1,299/mo in the terms but $1,999/mo in the site navigation. Free shipping, no membership fee, cancel anytime; refund requests must be emailed within 28 days.

Pros & Cons

Pros: No contract; full refund if not approved; ships within 48 business hours of approval; a stated full-refund right if medication has not shipped within 14 business days; injectable and oral formats.

Cons: No named legal entity, address, or pharmacy partners; contradictory pricing and refund language across its own pages; near-zero independent review history; celebrity-themed funnel pages over clinical substance.

How Do the Best Online Weight Loss Clinics Screen New Patients?

Look for the screen before you look at the price. The FDA approved Wegovy and Zepbound for adults with a BMI of 30+, or 27+ with at least one weight-related condition — that is the medical line a legitimate clinic should hold. On this list, TrimRx enforces the 27-plus-comorbidity rule explicitly, Ro demands a documented provider visit within the last 3 years, and Noom Med screens by BMI, history, and state. Our full methodology is on the how we rank page.

The money mechanic tells you even more. Clinics that charge nothing until a clinician approves you — bmiMD, TrimRx, and OMZO — have aligned their billing with their screening. A clinic that takes $299 before a provider ever reads your chart has not. And remember what these drugs are: GLP-1s were built for blood sugar first. Our guide to GLP-1s for diabetes vs weight loss explains why that history shapes who should — and should not — be approved.

Do the Best Online Weight Loss Clinics Use Video Visits or Async Forms?

Async is now the default, and it is not automatically worse. Hers, MEDVi, TrimRx, and ReadyRx all review intakes without a video call, usually within 24-48 hours, and licensed clinicians still make the call. bmiMD is the outlier that schedules a same-day live telehealth consult for everyone; MEDVi requires a virtual face-to-face in certain states because state law says so.

The line we draw is escalation. An async intake is fine if a human clinician is reachable afterward. A text-only pipeline with no video or phone option ever — ReadyRx’s model — is a ceiling, not a convenience. You are paying $99 to $449 a month. If the platform cannot put a clinician’s voice in your ear when something goes wrong, that discount is buying less care, not just less friction.

What Happens After the Prescription — and Who Answers When Side Effects Hit?

The prescription is the start of a 6-to-18-month clinical relationship, not the finish line. Nausea and other GI complaints were the most commonly reported side effects in the major GLP-1 trials, and they cluster during dose titration — exactly when you need messages answered. Our Ozempic side effects guide covers what is normal and what is not. Ro staffs a 24/7 care team. bmiMD and MEDVi advertise unlimited messaging; TrimRx includes monthly check-ins and dose adjustments. MEDVi’s 100 unanswered BBB complaints suggest its support promise and its inbox do not always match.

Set expectations with trial data, not marketing. In the STEP 1 trial, semaglutide 2.4 mg produced an average 14.9% body-weight loss over 68 weeks. In SURMOUNT-1, tirzepatide reached up to 20.9% over 72 weeks at the highest dose. Both required months of gradual dose escalation with clinical follow-up. Our guide on how fast GLP-1s work maps that timeline month by month — any clinic promising dramatically faster results is selling against the evidence.

Who Gets Rejected by an Online Weight Loss Clinic — and Why a No Is a Good Sign?

A clinic that never says no is a vending machine with a medical license attached. Legitimate disqualifiers include a personal or family history of medullary thyroid carcinoma or MEN2, pregnancy, pancreatitis history, and a BMI below the approved threshold. State law rejects people too: Noom Med will not ship compounded plans to Alabama, Louisiana, or Mississippi, and ReadyRx is missing from up to 9 states.

Here is the tell that costs nothing to check: ask what happens to your money if you are declined. bmiMD releases the card hold entirely. TrimRx charges $0 until approval. OMZO refunds consultation fees in full. Ro only bills its $39 membership if you are eligible. Compare that with platforms that keep processing fees or bury refund terms behind a signup wall. In a category where the FDA has publicly warned about unapproved GLP-1 drugs, the clinics willing to turn applicants away are the ones protecting everyone they approve.